Skip to main content
Top
Published in: BMC Hematology 1/2019

Open Access 01-12-2019 | Anemia | Research article

Effect of iron deficiency anemia on HbA1c in diabetic patients at Tikur Anbessa specialized teaching hospital, Addis Ababa Ethiopia

Authors: Absra Solomon, Mintewab Hussein, Mikias Negash, Abdurezak Ahmed, Fitsum Bekele, Daniel Kahase

Published in: BMC Hematology | Issue 1/2019

Login to get access

Abstract

Background

Hemoglobin A1C (HbA1c) is the predominant hemoglobin found in HbA1 fractions. A1c assay is the recommended assay for diagnosing diabetes and any condition that changes red cell turnover such as Iron deficiency Anemia (IDA), will lead to spurious A1C results. Therefore, the present study was aimed at determining the effect of IDA on HbA1c in diabetic patients attending Black Lion Specialized Teaching Hospital, Addis Ababa, Ethiopia.

Methods

A facility based comparative cross sectional study was conducted on 174 diabetic patients (87 with IDA and 87 without IDA) from April to July 2016. Socio demographic data and clinical conditions were collected using structured questionnaire. Venous blood was collected for performing Complete blood count (CBC) using Cell dyn 1800 hematology analyzer; Serum ferritin, performed by COBAS INTEGRA 400/800 Chemistry analyzer and HbA1c tests, performed by COBAS C 111 analyzer. Data was analyzed using SPSS version 21 software. Pearson’s correlation, chi-square, and independent t-tests were calculated. The data was presented as mean ± SD. A P-value of < 0.05 was taken as statistically significant.

Results

Mean hemoglobin (Hgb), hematocrit (HCT), Mean cell volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC) were lower in IDA group compared to non-IDA diabetic patients. HbA1c (%) level was significantly lower in IDA group (6.18 ± 1.57) compared with the non-IDA diabetic patients (7.74 ± 1.81) (p < 0.05).

Conclusion

HbA1c is significantly lower in diabetic patients with IDA compared to the non-IDA diabetic patients. Therefore, the authors believe that monitoring these patients using only HbA1c could be misleading, hence physicians and health care providers should take this into account before making any therapeutic decision. Detailed examination including large number of participants employing advanced laboratory techniques is recommended.
Appendix
Available only for authorised users
Literature
5.
go back to reference Singh K, Rao J, Mahdi JJ. Standard recommendation for interpretation of HbA1c graph in ion exchange HPLC method. Int J Med Invest. 2014;3(1):40–1. Singh K, Rao J, Mahdi JJ. Standard recommendation for interpretation of HbA1c graph in ion exchange HPLC method. Int J Med Invest. 2014;3(1):40–1.
6.
go back to reference Mahajan RD, Mishra B. Using glycated hemoglobin HbA1c for diagnosis of diabetes mellitus: an Indian perspective. Int J Biol Med Res. 2011;2(2):508–12. Mahajan RD, Mishra B. Using glycated hemoglobin HbA1c for diagnosis of diabetes mellitus: an Indian perspective. Int J Biol Med Res. 2011;2(2):508–12.
7.
go back to reference American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):S62–9.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):S62–9.CrossRef
9.
go back to reference Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013;87(2):98–104.PubMed Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013;87(2):98–104.PubMed
10.
go back to reference World Health Organization. Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. Vitamin and mineral nutrition information system. Geneva: World Health Organization; 2011. http: //www.who.int/vmnis/indicators/haemoglobin.pdf Accessed 22 Dec 2017 World Health Organization. Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. Vitamin and mineral nutrition information system. Geneva: World Health Organization; 2011. http: //www.who.int/vmnis/indicators/haemoglobin.pdf Accessed 22 Dec 2017
11.
go back to reference World Health Organization. The global prevalence of anemia in 2011. Geneva: World Health Organization; 2015. http://apps.who.int/iris/bitstream/10665/177094/1/9789241564960_eng.pdf, Accessed 22 Dec 2017) World Health Organization. The global prevalence of anemia in 2011. Geneva: World Health Organization; 2015. http://​apps.​who.​int/​iris/​bitstream/​10665/​177094/​1/​9789241564960_​eng.​pdf, Accessed 22 Dec 2017)
13.
go back to reference Kalasker V, Madhuri S, Kodliwadmath MV, Bhat H. Effect of Iron deficiency Anemia on glycosylated hemoglobin levels in non-diabetic Indian adults. Int J Med Health Sci. 2014;3(1):40–3. Kalasker V, Madhuri S, Kodliwadmath MV, Bhat H. Effect of Iron deficiency Anemia on glycosylated hemoglobin levels in non-diabetic Indian adults. Int J Med Health Sci. 2014;3(1):40–3.
16.
go back to reference Shekhar H, Mangukiya KK, Kaur A, Jadeja P. Effect of Iron deficiency on glycation of hemoglobin in non-diabetics. IJSN. 2014;5(3):477–9. Shekhar H, Mangukiya KK, Kaur A, Jadeja P. Effect of Iron deficiency on glycation of hemoglobin in non-diabetics. IJSN. 2014;5(3):477–9.
17.
go back to reference Chhabra RJ, Dhadhal R, Sodvadiya K. Study of glycated Haemoglobin (HbA1c) level in non-diabetic Iron deficiency Anemia. IJIRR. 2015;2(3):540–2. Chhabra RJ, Dhadhal R, Sodvadiya K. Study of glycated Haemoglobin (HbA1c) level in non-diabetic Iron deficiency Anemia. IJIRR. 2015;2(3):540–2.
18.
go back to reference Christy AL, Manjrekar PA, Babu RP, Hegde A, Rukmini MS. Influence of Iron deficiency Anemia on hemoglobin A1C levels in diabetic individuals with controlled plasma glucose levels. Iranian Biomed. 2014;18(2):88–93. Christy AL, Manjrekar PA, Babu RP, Hegde A, Rukmini MS. Influence of Iron deficiency Anemia on hemoglobin A1C levels in diabetic individuals with controlled plasma glucose levels. Iranian Biomed. 2014;18(2):88–93.
19.
go back to reference Manisha G, Nitin S, Ranjana M, Singh GA, Ritu G. Study of glycosylated hemoglobin in Iron deficiency Anemia. Sch J App Med Sci. 2016;4(2C):532–5. Manisha G, Nitin S, Ranjana M, Singh GA, Ritu G. Study of glycosylated hemoglobin in Iron deficiency Anemia. Sch J App Med Sci. 2016;4(2C):532–5.
Metadata
Title
Effect of iron deficiency anemia on HbA1c in diabetic patients at Tikur Anbessa specialized teaching hospital, Addis Ababa Ethiopia
Authors
Absra Solomon
Mintewab Hussein
Mikias Negash
Abdurezak Ahmed
Fitsum Bekele
Daniel Kahase
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Hematology / Issue 1/2019
Electronic ISSN: 2052-1839
DOI
https://doi.org/10.1186/s12878-018-0132-1

Other articles of this Issue 1/2019

BMC Hematology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.